pf 5901 has been researched along with chiniofon in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (80.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buckner, CK; England, DM; Fedyna, JS; Krell, RD; Robertson, JL; Saban, R; Will, JA | 1 |
| Anderson, DC; Hughes, H; Mitchell, JR; Shappell, SB; Smith, CW; Taylor, AA | 1 |
| Campbell, HF; Chan, WK; Galemmo, RA; Huang, FC; Johnson, WH; Lee, TD; Lin, CJ; Magnien, E; Tan, J; Youssefyeh, RD | 1 |
| Coutts, S; Gordon, R; Jolly, S; Khandwala, A; Sonnino, P; Van Inwegen, RG | 1 |
| Seale, JP; Temple, DM; Tennant, CM | 1 |
| Hatala, MA; Kraemer, R; Mullane, K; Sessa, W; Westlin, W | 1 |
| Chang, MS; Chiou, GC | 1 |
| Aharony, D; Krell, RD; Kusner, EJ; Marks, RL | 1 |
| Jolly, SR; Travis, J; Van Inwegen, RG | 1 |
| Barnes, N; Costello, J; Evans, J; Piper, P; Zakrzewski, J | 1 |
| Anderson, G; Fennessy, M | 1 |
| Augustine, MA; Bernstein, DF; Mufson, D; Serajuddin, AT; Sheen, PC | 2 |
| Beninati, L; Chang, J; Nielsen, ST | 1 |
| Chiou, GC; Chiou, LY | 1 |
1 review(s) available for pf 5901 and chiniofon
| Article | Year |
|---|---|
Studies of leukotriene antagonists and synthesis inhibitors in man.
Topics: Acetophenones; Asthma; Chromones; Epoprostenol; Humans; Hydroxyquinolines; Keto Acids; Leukotriene B4; Phenylbutyrates; Quinolines; SRS-A; Sulfones; Tetrazoles | 1988 |
14 other study(ies) available for pf 5901 and chiniofon
| Article | Year |
|---|---|
An examination of the influence of the epithelium on contractile responses to peptidoleukotrienes and blockade by ICI 204,219 in isolated guinea pig trachea and human intralobar airways.
Topics: Animals; Arachidonate 5-Lipoxygenase; Bronchi; Dose-Response Relationship, Drug; Epithelium; Guinea Pigs; Humans; Hydroxyquinolines; In Vitro Techniques; Indoles; Leukotriene Antagonists; Leukotriene E4; Leukotrienes; Lipoxygenase Inhibitors; Male; Muscle Contraction; Phenylcarbamates; Quinolines; SRS-A; Sulfonamides; Tosyl Compounds; Trachea | 1990 |
Comparison of antioxidant and nonantioxidant lipoxygenase inhibitors on neutrophil function. Implications for pathogenesis of myocardial reperfusion injury.
Topics: Antigens, Differentiation; Antioxidants; Cell Aggregation; Cell Movement; Humans; Hydroxyquinolines; Imidazoles; Leukotriene B4; Lipoxygenase Inhibitors; Macrophage-1 Antigen; Masoprocol; Myocardial Reperfusion Injury; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Quinolines; Receptors, Leukocyte-Adhesion; Thiazoles | 1990 |
Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene receptor antagonists. 1. Initial structure-activity relationships.
Topics: Animals; Azoles; Bronchodilator Agents; Chemical Phenomena; Chemistry; Guinea Pigs; Hydroxyquinolines; Leukotriene Antagonists; Lung; Phenyl Ethers; Quinolines; Receptors, Immunologic; Receptors, Leukotriene B4; Structure-Activity Relationship; Tetrazoles | 1990 |
REV 5901: an orally effective peptidoleukotriene antagonist, detailed biochemical/pharmacological profile.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Chromones; Coronary Circulation; Dose-Response Relationship, Drug; Guinea Pigs; Histamine; Hydroxyquinolines; Kinetics; Lung; Male; Methacholine Chloride; Methacholine Compounds; Muscle Contraction; Myocardial Contraction; Quinolines; Regional Blood Flow; SRS-A | 1987 |
Effects of a 5-lipoxygenase inhibitor, REV-5901, on leukotriene and histamine release from human lung tissue in-vitro.
Topics: Arachidonate Lipoxygenases; Histamine Release; Humans; Hydroxyquinolines; In Vitro Techniques; Lipoxygenase Inhibitors; Lung; Quinolines; SRS-A | 1987 |
Myocardial salvage induced by REV-5901: an inhibitor and antagonist of the leukotrienes.
Topics: Animals; Arachidonate Lipoxygenases; Dogs; Hydroxyquinolines; Leukotriene B4; Lipoxygenase Inhibitors; Male; Myocardial Infarction; Neutrophils; Quinolines; Rabbits; SRS-A | 1987 |
Prevention of lens protein-induced ocular inflammation with cyclooxygenase and lipoxygenase inhibitors.
Topics: Animals; Crystallins; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Eye Diseases; Female; Fluoresceins; Fluorophotometry; Hydroxyquinolines; Indomethacin; Inflammation; Lipoxygenase Inhibitors; Male; Prednisolone; Quinolines; Rabbits | 1989 |
Inhibition by REV-5901 of leukotriene release from guinea-pig and human lung tissue in vitro.
Topics: Animals; Calcimycin; Culture Techniques; Drug Interactions; Guinea Pigs; Histamine; Humans; Hydroxyquinolines; Leukotriene B4; Lipoxygenase Inhibitors; Lung; Male; Prostaglandin-Endoperoxide Synthases; Quinolines; SRS-A; Thromboxane B2; Time Factors | 1989 |
Effects of 5-lipoxygenase inhibition on cardiac anaphylaxis in isolated guinea pig hearts.
Topics: Acetophenones; Anaphylaxis; Animals; Arachidonate Lipoxygenases; Benzoquinones; Benzyl Compounds; Blood Pressure; Cardiomyopathies; Chromones; Coronary Circulation; Guinea Pigs; Heart; Hydroxamic Acids; Hydroxyquinolines; In Vitro Techniques; Indomethacin; Lipoxygenase Inhibitors; Male; Myocardium; Quinolines; Quinones; SRS-A; Tetrazoles | 1989 |
Effects of REV 5901, a 5-lipoxygenase inhibitor and leukotriene antagonist, on pulmonary responses to platelet activating factor in the guinea-pig.
Topics: Animals; Female; Guinea Pigs; Histamine; Hydroxyquinolines; In Vitro Techniques; Lipoxygenase Inhibitors; Lung; Lung Compliance; Male; Platelet Activating Factor; Quinolines; SRS-A | 1988 |
Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water-soluble drug from solid dispersions.
Topics: Administration, Oral; Animals; Biological Availability; Capsules; Chemical Phenomena; Chemistry, Physical; Dogs; Hydroxyquinolines; Male; Particle Size; Pharmaceutical Vehicles; Polyethylene Glycols; Quinolines; Solubility | 1988 |
REV 5901 and Ly 171,883 protect rat gastric mucosa against ethanol-induced damage.
Topics: Acetophenones; Animals; Azoles; Ethanol; Gastric Mucosa; Hydroxyquinolines; Lipoxygenase Inhibitors; Male; Quinolines; Rats; Rats, Inbred Strains; SRS-A; Tetrazoles | 1987 |
Preformulation study of a poorly water-soluble drug, alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol: selection of the base for dosage form design.
Topics: Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Drug Stability; Hydrogen-Ion Concentration; Hydroxyquinolines; Quinolines; Solubility; Spectrophotometry, Ultraviolet; Thermodynamics | 1986 |
Ocular anti-inflammatory action of a lipoxygenase inhibitor in the rabbit.
Topics: Animals; Endophthalmitis; Female; Hydroxyquinolines; Infusions, Intravenous; Intraocular Pressure; Lipoxygenase Inhibitors; Ophthalmic Solutions; Quinolines; Rabbits | 1985 |